Kura Oncology Reports Second Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
August 12, 2026 4:05 PM EDTKura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.77), $0.11 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $20.87 million versus the consensus estimate of $20.16 million.
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
... More


